ADAM12 and breast carcinoma: The discrepancy between expression patterns of ADAM12-L and ADAM12-S in breast cancer clinical samples suggests that ADAM12-L expression may be regulated at the post-transcriptional level, through microRNAs targeting the unique 3′UTR present in this variant.